Bock J L, Ben-Ezra J
Clin Chem. 1985 Nov;31(11):1884-7.
In this simultaneous assay of unbound phenobarbital, phenytoin, primidone, and carbamazepine, serum ultrafiltrate is prepared by centrifugation in disposable filter units (Centrifree Micropartition System, Amicon Corp.) and injected directly onto a reversed-phase liquid-chromatography column. Drugs in the effluent are detected by absorbance at 210 nm. The measured concentrations were not critically dependent on the exact conditions of ultrafiltration (rotor angle, speed or time of centrifugation, amount of sample filtered). Pooled serum containing all four drugs gave reproducible results in repeated analyses during several days. For comparison we assayed 113 clinical specimens for one or more of these drugs by this method, and for the total (bound plus unbound) concentration of each drug by immunoassay. For each drug there was a nearly linear relationship between the two types of measurements, except for six specimens that had unusually high fractions of unbound drug. This assay appears highly suitable for routine determination of the free, biologically active fraction of anticonvulsant drugs, possibly as an alternative to measurements of total drug concentrations.
在本次苯巴比妥、苯妥英、扑米酮和卡马西平的非结合型同时检测中,血清超滤液通过在一次性过滤装置(Centrifree微分离系统,密理博公司)中离心制备,并直接注入反相液相色谱柱。流出液中的药物通过210nm处的吸光度进行检测。测得的浓度并不严格依赖于超滤的确切条件(转子角度、离心速度或时间、过滤的样品量)。含有所有四种药物的混合血清在几天内的重复分析中给出了可重复的结果。为作比较,我们用此方法检测了113份临床标本中的一种或多种这些药物,并通过免疫测定法检测了每种药物的总(结合型加非结合型)浓度。对于每种药物,除了六个标本中非结合型药物比例异常高的情况外,两种测量方法之间存在近乎线性的关系。该检测方法似乎非常适合常规测定抗惊厥药物的游离、具有生物活性的部分,可能作为总药物浓度测量的替代方法。